These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 34381413)

  • 21. Moyamoya Disease and Spectrums of RNF213 Vasculopathy.
    Bang OY; Chung JW; Kim DH; Won HH; Yeon JY; Ki CS; Shin HJ; Kim JS; Hong SC; Kim DK; Koizumi A
    Transl Stroke Res; 2020 Aug; 11(4):580-589. PubMed ID: 31650369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Temporal profile of the vascular anatomy evaluated by 9.4-tesla magnetic resonance angiography and histological analysis in mice with the R4859K mutation of RNF213, the susceptibility gene for moyamoya disease.
    Kanoke A; Fujimura M; Niizuma K; Ito A; Sakata H; Sato-Maeda M; Morita-Fujimura Y; Kure S; Tominaga T
    Brain Res; 2015 Oct; 1624():497-505. PubMed ID: 26315378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Homozygosity for moyamoya disease risk allele leads to moyamoya disease with extracranial systemic and pulmonary vasculopathy.
    Fukushima H; Takenouchi T; Kosaki K
    Am J Med Genet A; 2016 Sep; 170(9):2453-6. PubMed ID: 27375007
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Hiraide T; Suzuki H; Momoi M; Shinya Y; Fukuda K; Kosaki K; Kataoka M
    Life (Basel); 2022 Apr; 12(4):. PubMed ID: 35455046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of RNF213 polymorphism in defining quasi-moyamoya disease and definitive moyamoya disease.
    Ishisaka E; Watanabe A; Murai Y; Shirokane K; Matano F; Tsukiyama A; Baba E; Nakagawa S; Tamaki T; Mizunari T; Tanikawa R; Morita A
    Neurosurg Focus; 2021 Sep; 51(3):E2. PubMed ID: 34469872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk: a meta-analysis and systematic review.
    Liao X; Deng J; Dai W; Zhang T; Yan J
    Environ Health Prev Med; 2017 Nov; 22(1):75. PubMed ID: 29165161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Research progress of moyamoya disease combined with renovascular hypertension.
    Liu E; Zhao H; Liu C; Tan X; Luo C; Yang S
    Front Surg; 2022; 9():969090. PubMed ID: 36090342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular structure and function of mysterin/RNF213.
    Morito D
    J Biochem; 2024 Apr; 175(5):495-505. PubMed ID: 38378744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between moyamoya syndrome and the RNF213 c.14576G>A variant in patients with neurofibromatosis Type 1.
    Phi JH; Choi JW; Seong MW; Kim T; Moon YJ; Lee J; Koh EJ; Ryu SK; Kang TH; Bang JS; Oh CW; Park SS; Lee JY; Wang KC; Kim SK
    J Neurosurg Pediatr; 2016 Jun; 17(6):717-22. PubMed ID: 26849809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional Characterization of the
    Kessler T; Wobst J; Wolf B; Eckhold J; Vilne B; Hollstein R; von Ameln S; Dang TA; Sager HB; Moritz Rumpf P; Aherrahrou R; Kastrati A; Björkegren JLM; Erdmann J; Lusis AJ; Civelek M; Kaiser FJ; Schunkert H
    Circulation; 2017 Aug; 136(5):476-489. PubMed ID: 28487391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel Multifaceted Roles for RNF213 Protein.
    Pollaci G; Gorla G; Potenza A; Carrozzini T; Canavero I; Bersano A; Gatti L
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced post-ischemic angiogenesis in mice lacking RNF213; a susceptibility gene for moyamoya disease.
    Ito A; Fujimura M; Niizuma K; Kanoke A; Sakata H; Morita-Fujimura Y; Kikuchi A; Kure S; Tominaga T
    Brain Res; 2015 Jan; 1594():310-20. PubMed ID: 25446450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Moyamoya disease-associated protein mysterin/RNF213 is a novel AAA+ ATPase, which dynamically changes its oligomeric state.
    Morito D; Nishikawa K; Hoseki J; Kitamura A; Kotani Y; Kiso K; Kinjo M; Fujiyoshi Y; Nagata K
    Sci Rep; 2014 Mar; 4():4442. PubMed ID: 24658080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RNF213 in moyamoya disease: Genotype-phenotype association and the underlying mechanism.
    Fang J; Yang X; Ni J
    Chin Med J (Engl); 2024 Jan; ():. PubMed ID: 38243713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cav-1 (Caveolin-1) and Arterial Remodeling in Adult Moyamoya Disease.
    Chung JW; Kim DH; Oh MJ; Cho YH; Kim EH; Moon GJ; Ki CS; Cha J; Kim KH; Jeon P; Yeon JY; Kim GM; Kim JS; Hong SC; Bang OY
    Stroke; 2018 Nov; 49(11):2597-2604. PubMed ID: 30355208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Moyamoya Disease Susceptibility Gene
    Roy V; Ross JP; Pépin R; Cortez Ghio S; Brodeur A; Touzel Deschênes L; Le-Bel G; Phillips DE; Milot G; Dion PA; Guérin S; Germain L; Berthod F; Auger FA; Rouleau GA; Dupré N; Gros-Louis F
    Stroke; 2022 Apr; 53(4):1263-1275. PubMed ID: 34991336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Role of RNF213 4810G>A and 4950G>A Variants in Patients with Moyamoya Disease in Korea.
    Park YS; An HJ; Kim JO; Kim WS; Han IB; Kim OJ; Kim NK; Kim DS
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29160859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RNF213 p.R4810K Polymorphism and the Risk of Moyamoya Disease, Intracranial Major Artery Stenosis/Occlusion, and Quasi-Moyamoya Disease: A Meta-Analysis.
    Wang Y; Mambiya M; Li Q; Yang L; Jia H; Han Y; Liu W
    J Stroke Cerebrovasc Dis; 2018 Aug; 27(8):2259-2270. PubMed ID: 29752070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development.
    Liu W; Morito D; Takashima S; Mineharu Y; Kobayashi H; Hitomi T; Hashikata H; Matsuura N; Yamazaki S; Toyoda A; Kikuta K; Takagi Y; Harada KH; Fujiyama A; Herzig R; Krischek B; Zou L; Kim JE; Kitakaze M; Miyamoto S; Nagata K; Hashimoto N; Koizumi A
    PLoS One; 2011; 6(7):e22542. PubMed ID: 21799892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RNF213 loss of function reshapes vascular transcriptome and spliceosome leading to disrupted angiogenesis and aggravated vascular inflammatory responses.
    Zhang L; Rashad S; Zhou Y; Niizuma K; Tominaga T
    J Cereb Blood Flow Metab; 2022 Nov; 42(11):2107-2122. PubMed ID: 35754359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.